Patients await your cure.
We make the wait shorter.
Specialists in recombinant
protein therapeutics.
Bionova is a biologics CDMO focused on the development and production of mAbs and other therapeutic proteins using mammalian cell culture processes.
Our team is your team.
With technical depth you’d expect from a larger biologics CDMO, our team offers a flexible, fast, client-first culture that our clients find refreshing.
Dedicated. Capable. Committed.
Bionova fuses technical expertise, best-in-class infrastructure and an attitude that makes problem-solving and client success our highest priority.
News & Happenings
September 9, 2026
Bionova Scientific and Minaris Announce Partnership to Accelerate Plasmid DNA Supply for Cell and Gene Therapy Manufacturing
February 4, 2026
Scarab Genomics and Bionova Enter Exclusive Licensing Partnership to Advance High-Efficiency Plasmid DNA Production
January 8, 2026
Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
July 3, 2025
Redefining Quality Culture at Bionova: A New Chapter Begins
May 7, 2025
Bionova Scientific Licenses ATUM’s Proprietary Transposon-Based Gene Delivery Technology to Accelerate & De-Risk Cell Line Development
March 20, 2025
Bionova Appoints Bionique Testing Laboratories as Preferred Provider for Mycoplasma Testing Services for Biologics Manufacturing
Get in touch
Let’s chat! Tell us how Bionova might help
your organization move forward.
